Eagle's Eye View: Your Weekly CV Update From ACC.org

104
Medicine #128

The weekly cardiovascular update from Kim Eagle, MD, MACC for ACC.org covering the hottest cardiovascular topics, from new clinical guidelines to practice-changing research and innovative quality initiatives and tools.

Recent Episodes
  • Carvedilol To Treat HFimpEF; Modifiable Lifestyle Factors & Cardiac Conduction Disease; Amiloride vs. Spironolactone for Resistant Hypertension
    May 28, 2025 – 07:27
  • Colchicine vs. Placebo in Reducing CV Events; DOACs vs. Warfarin After TAVR; CSP vs. BiVP and Echo Response
    May 21, 2025 – 07:08
  • ORBITA-2 & PCI; Blood Pressure Control & Increasing Medication Prescriptions; Rapid Initiation & Titration in GRMT for Patients with HFrEF
    May 14, 2025 – 08:19
  • Lp(a) and CV Risk; CRP Levels and High-Risk Vulnerable Plaque post-NSTEMI; Pulsed Field Ablation vs. Cryoablation for Paroxysmal AFib
    Apr 30, 2025 – 08:34
  • Weight Management in Pregnancy and CVD Risk; Impact of Statins Plus Ezetimibe Post-MI; PARTNER-3 Study 5-year Results
    Apr 23, 2025 – 06:52
  • Outcomes of Pre-ablation Transesophageal Echocardiograms; TAVI vs. SAVR in Women With Severe AS; Effects in the Use of Oral Anti-coagulants (OACs)
    Apr 16, 2025 – 07:26
  • Key Takeaways from ACC.25 Major Trials and Presentations
    Apr 2, 2025 – 09:25
  • Cardiogenic Shock Guidance; Mortality after Mitral Repair & TAVR; Direct-to-Physician Marketing Affects GDMT
    Mar 26, 2025 – 07:55
  • Smoking & CVD Risk; Sleep, Diabetes, & Women with Gestational Diabetes; Post-TAVR Imaging
    Mar 19, 2025 – 07:01
  • Short-term DAPT, PCI & High Bleeding Risk; Dapagliflozin & Heart Failure; Non-Pharmacologic Treatment of HF
    Mar 12, 2025 – 06:56
  • Identifying Myocardial Infarction after PCI; Myocardial Fibrosis & Severe Aortic Valve Stenosis; Anticoagulation & Cancer Diagnoses
    Mar 5, 2025 – 07:56
  • SGLT2 Inhibitors & Aortic Valve Stenosis; Early vs. Later Ablation for Afib; Sports Participation by Athletes with Cardiac Abnormalities
    Feb 26, 2025 – 08:47
  • Arrhythmia Recurrence & Rhythm Control after Catheter Ablation for AFib; Transthyretin Amyloid Cardiomyopathy & Tafamidis; Sodium Restriction & BP
    Feb 19, 2025 – 06:17
  • Blood Pressure & Postpartum; Beta Blockers & Takotsubo Syndrome; Secondary Prevention Worldwide
    Feb 12, 2025 – 07:51
  • Cardiac Rehab & Heart Failure, CV Care & Cancer Survivors, Bioprosthetic AVR vs Mechanical AVR in Younger Patients
    Feb 5, 2025 – 06:10
  • Cost-effectiveness of Polypills, Obesity and FH, Adverse Pregnancy Outcomes and Long-term HF Risk
    Jan 29, 2025 – 08:03
  • Left Atrial Appendage Occlusion & Stroke, Hypertrophic Cardiomyopathy in Children, Anticoagulation & COVID-19
    Jan 22, 2025 – 06:43
  • Top Trials, Journal Scans, and Takeaways of 2024
    Dec 23, 2024 – 05:37
  • What Cardiologists Should Know About Congenital Heart Disease, Cardiac Arrest and Death in Athletes, Arrhythmia After Stroke
    Dec 18, 2024 – 10:33
  • Management of Myocarditis; Sex Differences in PCI vs. CABG; RVOT Dysfunction in Repaired TOF
    Dec 11, 2024 – 09:35
  • Compression Tights in Patients With POTS, Platelet Function and Genetic Testing in PCI, Aspirin in Stent Patients Undergoing Noncardiac Surgery
    Dec 4, 2024 – 09:19
  • Prevalence of U.S. Overweight and Obesity, Consensus on CPR, Bleeding Risk Using NSAIDs With Anticoagulants
    Nov 27, 2024 – 08:05
  • Top Six Trials From AHA 2024: BROAD, SUMMIT, OPTION, CLEAR SYNERGY (Spironolactone and Colchicine), My Heart Your Heart
    Nov 21, 2024 –
  • Top Six Trials From AHA 2024: BROAD, SUMMIT, OPTION, CLEAR SYNERGY (Spironolactone and Colchicine), My Heart Your Heart
    Nov 21, 2024 – 12:55
  • Exercise Training in HCM; Management of Kawasaki Disease; Race, Social Determinants of Health, Polygenic Risk for CHD
    Nov 20, 2024 – 08:38
  • Transseptal Mitral Valve-in-Valve Procedure, Complete vs. Culprit-Only Revascularization in Older Patients, Hypertensive Pregnancy and MI Risk
    Nov 13, 2024 – 08:07
  • TAVR in Younger Patients; Atorvastatin vs. Rosuvastatin; Sedentary Behavior and Blood Pressure
    Nov 6, 2024 – 07:06
  • Top Four Trials from TCT 2024: EARLY TAVR, TRISCEND II for Tricuspid Regurgitation, ECLIPSE on orbital atherectomy, and CLEAR SYNERGY (OASIS 9) & colchicine treatment
    Nov 5, 2024 – 09:55
  • Discontinuing Drug Treatment in HFrEF, Race and Sacubitril/Valsartan Use in HF, Systolic BP Polygenic Risk Score Treatment Responses
    Oct 30, 2024 – 08:43
  • Real-time AI to Influence Clinical Decisions and Practice Towards Evidence-based Care: RAPIDxAI Trial
    Oct 29, 2024 –
  • Anthracycline Cardiotoxicity in Cancer Patients; Arrhythmias, Autonomic Dysfunction and COVID-19; Lowering Non–HDL Cholesterol After MI
    Oct 23, 2024 – 08:51
  • Semaglutide and BP, HF Risk Assessment Using Biomarkers, DAPT After Drug-Eluting Stenting in ACS
    Oct 16, 2024 – 09:51
  • CV Events After COVID Vaccine, Septal Reduction in Obstructive HCM, Acute Pulmonary Embolism Guideline Comparison
    Oct 9, 2024 – 10:33
  • Hospital Survival After AAA Repair, Myocardial Fibrosis and Aortic Stenosis, MRA Use in HF
    Oct 2, 2024 – 07:50
  • Risk Stratification in Nonischemic Dilated Cardiomyopathy, 2024 Guideline for Perioperative CV Management for Noncardiac Surgery, Lipoprotein(a) and Cardiovascular Disease
    Sep 25, 2024 – 08:53
  • Long-Term Outcomes in Pericarditis, Polygenic Risk Score and Predicting CVD, Aortic Disease in Children with FBN1-Related Marfan Syndrome
    Sep 18, 2024 – 10:36
  • Eight Practice-Changing Trials Featured at ESC Congress 2024
    Sep 12, 2024 – 11:02
  • Mechanical Circulatory Support in Infarct-Related Cardiogenic Shock, Anticoagulation Benefit in Device-Detected AFib, Semaglutide in HFpEF Patients
    Sep 11, 2024 – 08:25
  • SGLT2 Inhibitors vs. GLP-1 RAs in Diabetes, MRI Lesions After TAVR, Perioperative Management and Anticoagulants
    Sep 4, 2024 – 09:50
  • Social Determinants of Health in Cardiology, Aortopathy in Children, Cardiac CT Following Left Atrial Appendage Occlusion
    Aug 28, 2024 – 11:00
  • Genetics and Risk in Aortic Disease, Plant vs. Animal Fat in Cardiovascular Outcomes, Management of Cardiac Sarcoidosis
    Aug 21, 2024 – 10:38
  • Update to ACC/AHA Heart Failure Performance Measures; Quadruple Therapy and HF; ACEi, ARBs, and Chronic Kidney Disease
    Aug 14, 2024 – 08:27
  • Pulmonary Hypertension and HF, Obesity in Adolescents, Noncardiac Surgery After TAVR
    Aug 7, 2024 – 07:26
  • Fenestrated-Branched Endovascular Aortic Repair, Mortality and PCI, Lp(a) and Calcific Aortic Stenosis Progression
    Jul 31, 2024 – 09:41
  • Diuretics and HF, Implantable Cardioverter-Defibrillators and the Tricuspid Valve and Right Ventricle, Neurohormonal Blockade and HF
    Jul 24, 2024 – 08:47
  • Racial Differences in Diabetic Cardiomyopathy, Genetics of HCM, Semaglutide vs. Tirzepatide for Weight Loss
    Jul 17, 2024 – 08:59
  • Iron Repletion and Heart Failure, Ventricular Septal Defect and Acute Myocardial Infarction, Hemodynamic Assessment for HF
    Jul 10, 2024 – 09:09
  • Early Rhythm Control, Low-Dose Aspirin and Prevention, Autoimmune Diseases and Atherosclerosis
    Jul 2, 2024 – 08:37
  • In-office and At-Home Blood Pressure Measurement, Artificial Intelligence and Cardiovascular Care, Inflammatory Risk
    Jun 26, 2024 – 07:09
  • Severe Aortic Stenosis, Titration and Acute Heart Failure, Pacemakers After TAVR
    Jun 18, 2024 – 07:53
Recent Reviews
  • CVMD2
    Non critical summaries
    A good summary of recent trials. However critical appraisal is lacking. Proponent of “if it can be done it should be done.” Feb 19/25: there is no way "a point or two of systolic blood pressure reduction has a profound effect on lifetime cardiovascular risk". This defies credulity and lacks proof.
  • JMW-WW1
    Cheerleading for Cardiology
    Dr. Eagle has an enormous fund of knowledge and accomplishments. Sadly, however, his reviews are superficial and cheerleading rather than critical analysis.
  • dashuaige
    Concise, reliable and insightful
    A can’t miss podcast. Really great, super-concise discussion of newest studies and trials, all with Dr. Eagle’s thoughtful perspective. Keep it up, acc.org!!
  • EllauziR
    My favorite CV podcast!
    My favorite CV podcast!
  • Kandarp Patel B
    Kandarp Patel, Md facc Coreheart TN
    Excellent very helpful in clinical practice and resourceful
  • Gurtowsky7175
    Great Podcast
    Dr. Eagle does a wonderful job of reviewing current literature in cardiology. As a cardiology PA/MSL, it can be difficult to keep up with the many studies that come out each month. This podcast is helpful to stay up to date and is straight to the point. Highly recommend for busy providers!
  • ihgvduskcsug111
    Concise
    Gets to the point. No hot air.
  • NE_Heart_Doc
    Exceptional Review
    Excellent, objective, concise, and very intelligent review of clinically relevant studies. Dr. Eagle brings a tremendous amount of experience to this review which makes it very easy to know how to change your practice based upon these important studies.
  • nicky-leton
    Please give Dr Deepak Bhatt new AV equipment
    A great podcast overall. Concise and informative. Dr Kim Eagle is outstanding. Dr Deepak Bhatt occasionally steps in as a replacement. His podcasts are generally good as well, when you can make out what he is saying. Dismal microphone quality that seems like it could be easily fixed. The most recent podcasts are conducted jointly with Drs. Bhatt, Eagle and Dr Gabriel Steg. Dr Bhatt is the only one you can’t hear
  • Tay-Mum
    Great review app for residents and fellows
    Loved it. Shared it with my friends at cards. Thank you!!
  • Tiki bobcat
    Excellent
    This is an amazing recap of articulate edict from beginning to end.
Disclaimer: The podcast and artwork on this page are property of the podcast owner, and not endorsed by UP.audio.